Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening (Q44876752)

7 December 2017

title

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening (English)

1 reference

7 December 2017

1 reference

cervix uterine cancer

1 reference

14

Joakim Dillner

1 reference

7 December 2017

Pontus Naucler

1

1 reference

7 December 2017

Walter Ryd

2

1 reference

7 December 2017

Sven Törnberg

3

1 reference

7 December 2017

Anders Strand

4

1 reference

7 December 2017

Göran Wadell

5

1 reference

7 December 2017

Kristina Elfgren

6

1 reference

7 December 2017

Thomas Rådberg

7

1 reference

7 December 2017

Björn Strander

8

1 reference

7 December 2017

Ola Forslund

9

1 reference

7 December 2017

Bengt-Göran Hansson

10

1 reference

7 December 2017

Björn Hagmar

11

1 reference

7 December 2017

Bo Johansson

12

1 reference

7 December 2017

Eva Rylander

13

1 reference

7 December 2017

language of work or name

English

0 references

publication date

13 January 2009

1 reference

Journal of the National Cancer Institute

7 December 2017

published in

1 reference

7 December 2017

volume

101

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

88-99

1 reference

Trends in cancer of the cervix uteri in Sweden following cytological screening

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

International incidence rates of invasive cervical cancer after introduction of cytological screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN444

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJN444

1 reference

7 December 2017

1 reference